Trianni, Inc. and Antibody Solutions Announce Licensing Agreement

May 22, 2018 | By - | Filed in: Press Releases.

Trianni incorporated recent advances in DNA synthesis and genomic modification technology to develop its optimized therapeutic monoclonal antibody discovery platform.SAN FRANCISCO and SUNNYVALE, Calif., May 22, 2018 /PRNewswire/ — Trianni, Inc. (“TRIANNI”) and Antibody Solutions jointly announced today that Antibody Solutions has entered into a license agreement with TRIANNI for use of The Trianni Mouse™, a best-in-class fully humanized transgenic…

To post and circulate your own press release on FIR and the eTN Network  please click here 


Comments are closed here.